 | -$0.29 EPS Expected for Protagonist Therapeutics, Inc. (NASDAQ:PTGX) This Quarter
americanbankingnews.com - May 8 at 9:12 PM |
| Protagonist Therapeutics (NASDAQ:PTGX) Issues Earnings Results
americanbankingnews.com - May 5 at 4:08 PM |
 | Protagonist Reports First Quarter 2021 Financial Results and Provides Corporate Update
finance.yahoo.com - May 4 at 7:23 PM |
| Protagonist Therapeutics (PTGX) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 4 at 7:23 PM |
| Protagonist Therapeutics Completes Enrollment for Phase 2 Study of Rusfertide in Polycythemia Vera and Announces Plans for Data Update at an Upcoming Medical Meeting
finance.yahoo.com - April 27 at 8:41 AM |
| Is PTGX Stock A Buy or Sell?
finance.yahoo.com - April 24 at 7:31 PM |
| Protagonist Therapeutics (NASDAQ:PTGX) Trading Up 7.4%
americanbankingnews.com - April 22 at 1:58 PM |
| Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Given Consensus Rating of "Buy" by Analysts
americanbankingnews.com - April 18 at 2:32 AM |
| Protagonist Therapeutics (NASDAQ:PTGX) Shares Gap Up to $25.57
americanbankingnews.com - April 14 at 1:00 PM |
| Protagonist Therapeutics (NASDAQ:PTGX) Is In A Good Position To Deliver On Growth Plans
finance.yahoo.com - April 7 at 2:34 PM |
|
 | Shout! Acquires North American Rights to ‘The Show,’ Created By Alan Moore, From Protagonist (EXCLUSIVE)
msn.com - March 31 at 1:25 PM |
| Protagonist Announces Plans to Initiate a Global Phase 3 Study for Rusfertide in Polycythemia Vera Following Interactions with the U.S. Food & Drug Administration and the European Medicines Agency
finance.yahoo.com - March 22 at 8:29 PM |
| Protagonist Therapeutics (PTGX) Soars 5.9%: Is Further Upside Left in the Stock?
finance.yahoo.com - March 22 at 9:56 AM |
 | Protagonist Therapeutics, Inc. (PTGX) CEO Dinesh Patel on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - March 12 at 8:00 AM |
| Protagonist Therapeutics (PTGX) Reports Q4 Loss, Tops Revenue Estimates
finance.yahoo.com - March 10 at 11:24 PM |
| Protagonist Therapeutics: Q4 Earnings Snapshot
finance.yahoo.com - March 10 at 6:10 PM |
| Protagonist Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Corporate Update
finance.yahoo.com - March 10 at 6:10 PM |
| Protagonist Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results
finance.yahoo.com - March 3 at 8:55 AM |
| Will Protagonist Therapeutics (PTGX) Report Negative Q4 Earnings? What You Should Know
finance.yahoo.com - March 2 at 2:12 PM |
| Protagonist Therapeutics to Participate in the H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - March 2 at 9:11 AM |
| Protagonist Therapeutics to Participate in the SVB Leerink Virtual 10th Annual Global Healthcare Conference
finance.yahoo.com - February 16 at 8:27 AM |
| Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Insiders Increased Their Holdings
finance.yahoo.com - January 7 at 11:15 AM |
| Protagonist Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 4 at 8:57 AM |
| MannKind (MNKD) Looks Good: Stock Adds 5.6% in Session
finance.yahoo.com - December 29 at 1:03 PM |
| Protagonist Therapeutics Announces First Subject Dosed in Phase 1 Study of Oral IL-23 Receptor Antagonist PN-235 (JNJ-77242113)
finance.yahoo.com - December 16 at 7:45 AM |
| Protagonist Therapeutics, Inc. Announces Closing of $115 Million Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
finance.yahoo.com - December 15 at 8:17 PM |
| Is PTGX A Good Stock To Buy Now?
finance.yahoo.com - December 13 at 12:39 PM |
| Protagonist Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
finance.yahoo.com - December 10 at 5:18 PM |
|
| Protagonist Announces Results of Large-Scale Analysis of Current Treatment Patterns Revealing Significant Opportunity to Improve the Standard of Care for Patients with Polycythemia Vera Across Broad Population Categories
finance.yahoo.com - December 7 at 11:34 AM |
| Protagonist Announces Updated Phase 2 Data Presented at ASH Annual Meeting Supporting Long Term Efficacy of Hepcidin Mimetic PTG-300 in the Treatment of Polycythemia Vera
finance.yahoo.com - December 6 at 3:30 PM |
| Protagonist's Hepcidin Mimetic Candidate PTG-300 Receives Fast Track Designation from the U.S. Food and Drug Administration for Development in the Treatment of Polycythemia Vera
finance.yahoo.com - December 2 at 9:24 AM |
| Protagonist to Host Conference Call and Webcast to Provide a Research Update on December 9, 2020
finance.yahoo.com - November 30 at 7:21 AM |
| Protagonist Therapeutics to Present at the Virtual Piper Sandler 32nd Annual Healthcare Conference
finance.yahoo.com - November 25 at 9:24 AM |
| Protagonist Therapeutics to Participate in the Jefferies Virtual 2020 London Healthcare Conference
finance.yahoo.com - November 11 at 6:00 PM |
| Protagonist Therapeutics (PTGX) Reports Q3 Loss, Tops Revenue Estimates
finance.yahoo.com - November 4 at 10:02 PM |
| Protagonist Therapeutics Reports Third Quarter Financial Results and Provides Corporate Update
finance.yahoo.com - November 4 at 5:02 PM |
| Protagonist Therapeutics to Present Updated Clinical Data for Hepcidin Mimetic PTG-300 in Polycythemia Vera at the American Society for Hematology (ASH) 2020 Annual Meeting
finance.yahoo.com - November 4 at 12:01 PM |
| Protagonist Therapeutics, Janssen advance oral IL-23 receptor antagonists program
seekingalpha.com - October 30 at 9:34 AM |
| Protagonist Therapeutics Announces Advancement of Oral IL-23 Receptor Antagonists Program in Collaboration with Janssen
finance.yahoo.com - October 29 at 6:32 PM |
| Protagonist Therapeutics (PTGX) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
finance.yahoo.com - October 28 at 1:58 PM |
| Protagonist Therapeutics's lead asset an Orphan Drug in Europe for a type of blood cancer
seekingalpha.com - October 21 at 8:05 AM |
| Protagonist Therapeutics Receives Orphan Drug Designation from the European Medicines Agency for PTG-300 in Polycythemia Vera
finance.yahoo.com - October 21 at 8:05 AM |
| Protagonist Therapeutics, Inc. (PGF.SG)
au.finance.yahoo.com - October 11 at 5:05 PM |
| Protagonist Therapeutics to Participate in the H.C. Wainwright 22nd Annual Global Investment Conference
finance.yahoo.com - September 10 at 9:01 PM |
| Protagonist Therapeutics to Host PTG-300 Opportunity Update Webinar
finance.yahoo.com - September 2 at 7:43 PM |
| Can You Imagine How Protagonist Therapeutics' (NASDAQ:PTGX) Shareholders Feel About The 64% Share Price Increase?
finance.yahoo.com - August 25 at 1:23 PM |
| Can You Imagine How Protagonist Therapeutics' (NASDAQ:PTGX) Shareholders Feel About The 64% Share Price Increase?
finance.yahoo.com - August 25 at 1:23 PM |
 | Protagonist Therapeutics Inc (NMQ:PTGX) price about to hit new 52-week high
uk.finance.yahoo.com - August 20 at 10:01 AM |
| Protagonist Appoints Sarah O'Dowd to Board of Directors
finance.yahoo.com - August 13 at 7:25 PM |
 | Protagonist ramps up construction on Lower South End brewery
bizjournals.com - August 7 at 6:56 PM |
